Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Attal

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Leukemia|April 30, 2010
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trialP Moreau, C Hulin, G Marit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Bone Marrow Transplantation|February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaI Avivi, C Canals, J-P Vernant, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.
Leukemia|June 23, 2006
Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotypeV Bardet, L D Costa, C Elie, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Leukemia|April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myelomaX Leleu, G Fouquet, B Hebraud, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Bone Marrow Transplantation|May 1, 1997
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)E Jourdan, D Maraninchi, J Reiffers, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Leukemia|April 30, 2010
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trialP Moreau, C Hulin, G Marit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Bone Marrow Transplantation|February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaI Avivi, C Canals, J-P Vernant, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.
Leukemia|June 23, 2006
Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotypeV Bardet, L D Costa, C Elie, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Leukemia|April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myelomaX Leleu, G Fouquet, B Hebraud, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Bone Marrow Transplantation|May 1, 1997
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)E Jourdan, D Maraninchi, J Reiffers, et al.
Pageof 16